Honeybees in the U.S. have developed widespread resistance to the antibiotic tetracycline, likely as a result of decades of exposure to preventive antibiotics in domesticated hives, a new study has found. In tests conducted on bees in several countries, scientists from Yale University say they identified eight tetracycline resistance genes in U.S. honeybees that were largely absent in bees found in places where the antibiotics are banned. In the U.S., the use of oxytetracycline — a compound similar to tetracycline — has been common since the 1950s to help prevent outbreaks of “foulbrood,” a bacterial disease that can devastate honeybee hives. “There’s a pattern here, where the U.S. has these genes and the other [countries] don’t,” said Nancy Moran, a lead author of the study published in the journal mBio. The authors warn that the treatment meant to prevent disease and strengthen honeybee hives in the U.S. may have actually weakened the bees’ ability to fight off other pathogens.
U.S. Honeybees Have Developed Resistance to Antibiotic, Study Says
More From E360
-
INTERVIEW
At 11,500 Feet, a ‘Climate Fast’ to Save the Melting Himalaya
-
Oceans
Octopuses Are Highly Intelligent. Should They Be Farmed for Food?
-
Climate
Nations Are Undercounting Emissions, Putting UN Goals at Risk
-
Solutions
As Carbon Air Capture Ramps Up, Major Hurdles Remain
-
ANALYSIS
How China Became the World’s Leader on Renewable Energy
-
Biodiversity
As Flooding Increases on the Mississippi, Forests Are Drowning
-
Climate
In Mongolia, a Killer Winter Is Ravaging Herds and a Way of Life
-
Energy
In Rush for Lithium, Miners Turn to the Oil Fields of Arkansas
-
Food & Agriculture
How a Solar Revolution in Farming Is Depleting World’s Groundwater
-
INTERVIEW
What Will It Take to Save Our Cities from a Scorching Future?
-
Climate
Rain Comes to the Arctic, With a Cascade of Troubling Changes
-
Health
Plastics Reckoning: PVC Is Ubiquitous, But Maybe Not for Long